Funding for this research was provided by:
Received: 24 September 2021
Accepted: 25 March 2022
First Online: 12 May 2022
: The study was conducted in accordance with the Declaration of Helsinki and approved and overseen by a centralized Independent Review Board (IRB) in the US (Copernicus Group IRB reference: ADE1-15-747). A study protocol was developed by the research team and approved by the IRB. Study procedures ensured that caregivers provided consent by signing an informed consent form (ICF) prior to the collection of any data and caregivers were told that they could withdraw from the study at any time.
: Not applicable.
: Sophi Tatlock, Sarah Bentley, and Rob Arbuckle are employed by Adelphi Values Ltd, and Linda Abetz-Webb is employed by Patient-Centered Outcome Assessments (P-COA), both of which are healthcare research consultancies contracted to conduct this research on behalf of Janssen Pharmaceuticals Inc. Jane Scott was an employee of Janssen Pharmaceuticals Inc at the time of the research.